Literature DB >> 1413457

Anthelmintic activity of paraherquamide in calves.

W L Shoop1, B F Michael, H W Haines, C H Eary.   

Abstract

Paraherquamide, an oxindole alkaloid metabolite of Penicillium paraherquei and Penicillium charlesii, was tested against the adult stages of nine common gastrointestinal and lung nematodes of calves at single, oral dosages of 0.5, 1.0, 2.0 or 4.0 mg kg-1. At dosages 1.0-4.0 mg kg-1 there was 95% or more removal of Haemonchus placei, Ostertagia ostertagi, Trichostrongylus axei, Trichostrongylus colubriformis, Cooperia oncophora, Nematodirus helvetianus, Oesophagostomum radiatum, and Dictyocaulus viviparus. Cooperia punctata, the dosage-limiting species, was virtually unaffected by any dosage except the highest, which produced an efficacy of 89%. The 0.5 mg kg-1 dosage was 95% or more efficacious against H. placei, O. ostertagi, C. oncophora, and D. viviparus, but weaknesses were evident against the other five species. No adverse reaction was observe in any calf.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413457     DOI: 10.1016/0304-4017(92)90167-8

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Studies Towards Paraherquamides E & F and Related C-labeled Putative Biosynthetic Intermediates: Stereocontrolled Synthesis of the α-Alkyl-β-Methylproline Ring System.

Authors:  Konrad Sommer; Robert M Williams
Journal:  Tetrahedron       Date:  2008-07-21       Impact factor: 2.457

2.  Studies on Paraherquamide Biosynthesis: Synthesis of Deuterium-Labeled 7-Hydroxy-Pre-Paraherquamide, a Putative Precursor of Paraherquamides A, E & F.

Authors:  Konrad Sommer; Robert M Williams
Journal:  Tetrahedron       Date:  2009-04-18       Impact factor: 2.457

3.  Potential drug development candidates for human soil-transmitted helminthiases.

Authors:  Piero Olliaro; Jürg Seiler; Annette Kuesel; John Horton; Jeffrey N Clark; Robert Don; Jennifer Keiser
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.